SCA
SLAB icon

Salient Capital Advisors’s Silicon Laboratories SLAB Stock Holding History

Salient Capital Advisors’s Portfolio SLAB Stock Details SLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,905
Closed -$214K – 242
2017
Q1 		$214K Buy
+2,905
New +$203K ﹤0.01% 243

Other funds holding SLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Salient Capital Advisors's SLAB Position: Q2 2017 in Review

Salient Capital Advisors sold out of Silicon Laboratories (SLAB) in Q2 2017, closing a stake of 2,905 shares — an estimated $214K sold.

Salient Capital Advisors first reported a position in SLAB in Q1 2017 and held it in 1 quarter. The position peaked at $214K in Q1 2017. 233 funds tracked by Wall St. Rank hold SLAB as of Q2 2017.

  • Salient Capital Advisors reported no remaining Silicon Laboratories position as of Q2 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 2,905 Silicon Laboratories shares in Q2 2017, an estimated $214K.
  • Salient Capital Advisors first reported a position in Silicon Laboratories in Q1 2017 and held it in 1 quarter.
  • Salient Capital Advisors's Silicon Laboratories position peaked at $214K in Q1 2017.
  • 233 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2017.

Based on Salient Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.